January 2024

Dr. Susan Trieu sits down with Specialty Pharmacy Continuum to discuss what's ahead for the specialty drug market this year.

2023 was a landmark year for specialty drugs - for R&D and new FDA approvals. Dr. Susan Trieu, our head of specialty clinical strategy, is closely following the trends. She recently shared a forecast in a video interview with Specialty Pharmacy Continuum. 

The takeaway? Specialty pharmacy growth is here to stay.

"Research and development in the pharmaceutical space and specialty has been a hot topic for a long time because of the cost of specialty medications. Although a small percentage of the actual population uses a specialty drug, it is accounting for over 50% of actual healthcare spend."

"Although a small percentage of the population uses a specialty drug, it is accounting for over 50% of actual healthcare spend."

Watch the full interview at the link below.